SPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation phase - Fakih, M; Wang, D; Harb, W (Annals of Oncology, 2019)
et al.